英文名称
(AlphaR,BetaS)-rel-Bedaquiline-d6
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
(aR,bS)-rel-Bedaquiline-d6 is the labelled analogue of (aR,bS)-rel-Bedaquiline (B119555), a promising diarylquinoline candidate in clinical development for the treatment of tuberculosis. (aR,bS)-rel-Bedaquiline inhibits mycobacterial ATP synthase and displays high activity against both drug-susceptible and multidrug-resistant strains of Mycobacterium tuberculosis.